Drugs / Lecitone®Se
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01708005 Comparator | Nov 2012 → Nov 2014 | cognitive impairment with or without cerebellar ataxia | University Hospital, Angers | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LecitoneSe | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01708005 ↗ |
| Route | Oral | “oral intake of Lecitone®Se-Vitamin D3” NCT01708005 ↗ |